LPCN ▲ +53.6% - Lipocine Inc.
$LPCN LPCN - Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
07-OCT-2026 08:01 AM ET
Share this post
More filings for $LPCN
LPCN ▲ +35.9% - Lipocine Inc.Oct 7, 2026LPCN ▼ -4.8% - Lipocine Inc.Sep 14, 2026LPCN - Lipocine Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $LPCN filing history →💬 Comments
Loading comments…
Leave a comment